mobocertinib,Amivantamab,trastuzumab deruxtecan
Takeda,Janssen,daiichi sankyo,astrazeneca
['nsclc', 'lung', 'sclc']
unanswered questions in ex20;insertions and her2 mutations in nsclc. expanding the field of egfr targeted therapies in lung cancer . at 
Born in Majorca. Medical oncologist. Clinical researcher. Focused in lung cancer. World citizen. Major concerns: human inequality and blue planet environment